Study identifies molecular mechanisms behind gestational diabetes progression

Among those who have had gestational diabetes, about 35% will develop type 2 diabetes within a decade.

vTv announces Phase III plans for type 1 diabetes drug cadisegliatin – Pharmaceutical Technology

Image Credit: Shutterstock/antoniodiaz vTv Therapeutics plans to initiate a Phase III clinical trial for cadisegliatin for treating type 1 diabetes (T1D) by the end of

August 14, 2023

Empowering Change: How Hologic is Shaping the Future of Women’s Healthcare

Hologic, Inc. is a global medical technology innovator primarily focused on improving women’s health and well-being through early detection and treatment.

March 8, 2024

Opinion | Fighting Misinformation Like a Doctor

Thomas is a hospitalist in New York State. My first encounter with each patient follows a similar pattern. I hit the hand sanitizer near the

December 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.